| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/12/2007 | CN101035793A Difluoro-substituted imidazopyridines |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |
| 09/12/2007 | CN101033230A Cmptothecine derivative and application thereof |
| 09/12/2007 | CN101033229A Separation of monosomic tetrandrine from tetrandrine total alkaloid by adsorption resin method |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268144 Regiospecific synthesis of rapamycin 42-ester derivatives |
| 09/11/2007 | US7268143 Isoquinoline derivatives and methods of use thereof |
| 09/11/2007 | US7268142 4-chloro-N-[2-(6,7-dimethoxy-quinazolin-4-yl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-benzenesulfonamide; schizophrenia, central nervous system disorders |
| 09/11/2007 | US7268138 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 09/07/2007 | WO2007101270A1 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007098961A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/07/2007 | WO2007029156A3 Isoindoledione derivatives as adrenergic receptor antagonists |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/06/2007 | US20070208050 Process for preparing irinotecan |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070207196 Tocopherol-modified therapeutic drug compound formulations |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1829879A1 Amino pyrimidine compounds for the treatment of inflammatory disorders |
| 09/05/2007 | EP1829869A1 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/05/2007 | EP1828196A2 Stereoselective process and crystalline forms of a camptothecin |
| 09/05/2007 | EP1828195A2 Substituted phenols as active agents inhibiting vegf production |
| 09/05/2007 | EP1828181A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 09/05/2007 | EP1827420A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 09/05/2007 | CN101031297A Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 09/05/2007 | CN101029050A Synthesis of 7-ethyl-N-camptothecin oxide |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 08/30/2007 | WO2007097301A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 08/30/2007 | WO2007095696A1 Polyketide xanthones and uses thereof |
| 08/30/2007 | WO2007041195A3 Macroheterocylic compounds as kinase inhibitors |
| 08/30/2007 | WO2007010412A3 Syntheses and preparations of narwedine and related novel compounds |
| 08/30/2007 | WO2006113837A3 Inhibitors of akt activity |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203172 Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same |
| 08/30/2007 | US20070203170 immunomodulatory agent useful in treatment of restenosis and immune and autoimmune diseases |
| 08/30/2007 | US20070203169 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same |
| 08/30/2007 | US20070203168 Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same |
| 08/30/2007 | US20070203167 2-(Hetero)-aryl substituted tetrahydrochinoline |
| 08/30/2007 | US20070203133 Substituted 5,12-diaza-benzoanthracene analogues |
| 08/30/2007 | US20070203127 Antibacterial Agents |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 08/30/2007 | CA2642933A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 08/29/2007 | EP1824857A1 Use of centrifugal partition chromatography for purifying galanthamine |
| 08/29/2007 | EP1824842A2 Inhibitors of 11- hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| 08/29/2007 | EP1824826A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 08/29/2007 | EP1824825A1 Substituted pyridoxines as anti-platelet agents |
| 08/29/2007 | EP1824820A2 Substituted tetracyclic tetrahydrofuran,pyrrolidine and tetrahydrothiophene derivatives |
| 08/29/2007 | EP1670767A4 Resolution of a narwedine amide derivative |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | CN101027060A Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN100334089C Production method of 9-nitro camptothecin |
| 08/29/2007 | CN100334086C Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives |
| 08/28/2007 | US7262300 New crystalline monohydrates and crystalline anhydrates of gaboxadol; suitable for oral dosage administration |
| 08/28/2007 | US7262295 Wear resistance coating containing photochromic compound and polymer |
| 08/23/2007 | WO2007095628A1 Pyrazoloquinolones are potent parp inhibitors |
| 08/23/2007 | WO2007094071A1 Agent for improvement of hepatic function |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007093363A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/23/2007 | US20070197616 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197546 Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonists |
| 08/23/2007 | US20070197527 Bicyclic heteroaromatic compounds |
| 08/23/2007 | US20070197518 particularly for the treatment of infections caused by resistant strains of bacteria; 9,10- difluoro-2,4-dimethyl-8-pyrazin-2-yl-1,2,4,4a- tetrahydro-2'H,6H- spiro[1,4-oxazino[4,3-a]quinoline-5,5'- pyrimidine]- 2',4',6'(1'H,3'H)-trione |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197500 3-(2,3-Dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)-N,N-dimethyl-2-(pyridin-2-ylmethyl)propanamide; opioid receptor-like 1 antagonist; reduced inhibitory activity at HERG potassium channel; analgesic; side effect reduction; neurpathic and other pain |
| 08/23/2007 | US20070197393 Tricyclic benzoylpyrazole derivatives |
| 08/23/2007 | CA2641776A1 Pyrazoloquinolones are potent parp inhibitors |
| 08/23/2007 | CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2636605A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/22/2007 | EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 08/22/2007 | EP1819690A2 Chroman compounds |
| 08/22/2007 | EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof |
| 08/22/2007 | EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 08/22/2007 | EP1615919B1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 08/22/2007 | EP1537122B1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 08/22/2007 | EP1373214B1 Rylene derivatives and their use as dyes |
| 08/22/2007 | EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 08/22/2007 | CN101022805A Process to prepare camptothecin derivatives |
| 08/22/2007 | CN101020699A Metal complex with liriodenine as ligand and its synthesis process and use |
| 08/22/2007 | CN101020689A 1-(3-indolyl)-6,7-methylene dioxy-1,2,3,4-tetrahydro isoquinoline derivative and its prepn and use |
| 08/22/2007 | CN101019866A Medicine for treating hepatitis B |
| 08/21/2007 | CA2264066C Antiparasitic compounds isolated from fermentation of nodulisporium sp |
| 08/16/2007 | WO2007092000A1 Inhibitors of hcv replication |
| 08/16/2007 | WO2007091736A1 Novel coumarin derivative having antitumor activity |
| 08/16/2007 | WO2007090854A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders |
| 08/16/2007 | WO2007090853A1 Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders |
| 08/16/2007 | WO2007090852A1 Amino pyrimidine compounds for the treatment of inflammatory disorders |
| 08/16/2007 | WO2007075825A3 Lipophilic anticancer drug compounds |
| 08/16/2007 | WO2006079637A8 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/16/2007 | WO2006074046A3 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 08/16/2007 | US20070191469 Novel tetracyclic tetrahydrofuran derivatives |
| 08/16/2007 | US20070191447 Novel heterocyclic compound |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191417 Quinoline 3-amino chroman derivatives |